Efficacy of SP and XP for HER2-negative unresectable advanced recurrent gastric cancer varies by histologic type

Hisato Kawakami, Kazuhiro Nishikawa, Toshio Shimokawa, Kazumasa Fujitani, Shigeyuki Tamura, Shunji Endo, Michiya Kobayashi, Junji Kawada, Yukinori Kurokawa, Akira Tsuburaya, Takaki Yoshikawa, Junichi Sakamoto, Taroh Satoh for HERBIS-2, HERBIS-4A and XParTS II Study Investigators

第95 回日本胃癌学会総会 2023.2.23～25 札幌